MDS is a bone marrow failure disorder
MDS is a blood cancer
Learn More >

Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

Pracinostat and Azacitidine vs. Hu5F9-G4 in Combination With Azacitidine

HomeForumsPatient Message BoardPracinostat and Azacitidine vs. Hu5F9-G4 in Combination With Azacitidine

This topic contains 0 replies, has 1 voice, and was last updated by  denver 2 months, 1 week ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #36607

    denver
    Participant

    Hi, I am considering two of the above clinical trials to treat RAEB-2 (17% blasts) with Monosomy 7 and 4 other mutations. We have not yet begun any treatment.

    Monosomy 7 has shown promise with Azacitidine (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936359/), but I am wondering if anyone has an opinion on the two experimental drugs Pracinostat vs. Hu5F9-G4. The trials are at two different locations and will determine where we are treated.

    Trial Numbers:
    Pracinostat – NCT03151304
    Hu5F9-G4 – NCT03248479

    Thanks!

    • This topic was modified 2 months, 1 week ago by  .
Viewing 1 post (of 1 total)

Register for an account, or login to post to our message boards. Click here.

You must be logged in to reply to this topic.

Review answers to commonly asked questions or get answers to your questions from an MDS expert